Because it successfully transformed.
At that time, when fujifilm Company was wandering at the crossroads, it had the idea of jumping off a building. However, all the staff are thinking about one question together: can the company's core thin film technology be used for other purposes? Finally, someone thought: How about we try cosmetics?
Film and cosmetics, the concepts of these two products are different, how to integrate them? As a result, a year later, fujifilm Company successfully developed a series of red cosmetics, adopting the company's most traditional membrane technology and hydrolysis technology.
The successful development of cosmetics made fujifilm company taste the sweetness of getting involved in the health industry. Therefore, the company shifted its focus to the health industry, combined the most advanced artificial intelligence technology with the traditional image processing technology in fujifilm, and developed AI recognition technology for identifying and extracting organ regions. This medical system, which combines medical imaging and informatics AI technology, has become the new medical technology brands of fujifilm Company, named "REiLI".
"REiLI" technology can accurately identify the shape of organs in image examination, find the parts different from normal tissue structure, remind doctors of this abnormal part in time, explain this abnormal feature, point out the potential disease state of patients, and help radiologists make clinical decisions by reducing the time of image interpretation.
The birth of this technology means that the artificial intelligence physical examination will be more accurate than the doctor's experience physical examination. At the same time, fujifilm has also developed FCTPixel Shine technology, which can use AI algorithm to achieve efficient image processing at a very low radiation dose. At present, fujifilm is still promoting the development of CAD (Computer Aided Design System) for the detection of major organs, lung cancer and cerebral infarction.
Most notably, fujifilm also acquired the technology of American iPS cell refining equipment and became the patent supplier of this universal cell culture manufacturing equipment.
Under the background of the sharp reduction of photographic film market, fujifilm actively seeks transformation, and has formed six business fields, including medical and health, high-performance materials, electronic imaging, photoelectricity, printing art and document processing, and has become a diversified scientific and technological innovation enterprise. Among them, medical and health services have become the leader of fujifilm's future development, and fujifilm has also become an important affiliated enterprise of Japanese regenerative medicine. (Text/Xu Jingbo)